Perk Labs Inc.
PKLBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.09 | 0.04 | 0.03 |
| FCF Yield | -72.96% | -22.61% | -26.95% | -59.01% |
| EV / EBITDA | -0.84 | -6.46 | -1.77 | -0.82 |
| Quality | ||||
| ROIC | -899.92% | -111.22% | -250.22% | -169.84% |
| Gross Margin | 29.46% | 5.21% | -6.15% | -14.96% |
| Cash Conversion Ratio | 0.64 | 1.48 | 0.50 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | -20.93% | -3.38% | -66.47% | -68.93% |
| Free Cash Flow Growth | 2.05% | 1.19% | 53.66% | 70.16% |
| Safety | ||||
| Net Debt / EBITDA | 0.08 | 0.85 | 0.13 | 0.25 |
| Interest Coverage | -33.66 | -59.72 | -98.91 | -399.01 |
| Efficiency | ||||
| Inventory Turnover | 14.67 | 3.02 | 6.88 | 0.00 |
| Cash Conversion Cycle | -2,590.22 | -3,157.38 | -1,696.34 | -3,199.38 |